001     289191
005     20240425122528.0
024 7 _ |a 10.1016/S1470-2045(23)00636-8
|2 doi
024 7 _ |a pmid:38547899
|2 pmid
024 7 _ |a 1470-2045
|2 ISSN
024 7 _ |a 1474-5488
|2 ISSN
024 7 _ |a altmetric:161172070
|2 altmetric
037 _ _ |a DKFZ-2024-00625
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Schlander, Michael
|0 P:(DE-He78)1f315d09721b91091df1ba78eb65cbaf
|b 0
|e First author
|u dkfz
245 _ _ |a The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions.
260 _ _ |a London
|c 2024
|b The Lancet Publ. Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1712068176_3751
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:C100#LA:C100#
520 _ _ |a Loss of income and out-of-pocket expenditures are important causes of financial hardship in many patients with cancer, even in high-income countries. The far-reaching consequences extend beyond the patients themselves to their relatives, including caregivers and dependents. European research to date has been limited and is hampered by the absence of a coherent theoretical framework and by heterogeneous methods and terminology. To address these shortages, a task force initiated by the Organisation of European Cancer Institutes (OECI) produced 25 recommendations, including a comprehensive definition of socioeconomic impact from the perspective of patients and their relatives, a conceptual framework, and a consistent taxonomy linked to the framework. The OECI task force consensus statement highlights directions for future research with a view towards policy relevance. Beyond descriptive studies into the dimension of the problem, individual severity and predictors of vulnerability should be explored. It is anticipated that the consensus recommendations will facilitate and enhance future research efforts into the socioeconomic impact of cancer and cancer care, providing a crucial reference point for the development and validation of patient-reported outcome instruments aimed at measuring its broader effects.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Neoplasms: epidemiology
|2 MeSH
650 _ 2 |a Neoplasms: therapy
|2 MeSH
650 _ 2 |a Academies and Institutes
|2 MeSH
650 _ 2 |a Consensus
|2 MeSH
650 _ 2 |a Socioeconomic Factors
|2 MeSH
700 1 _ |a van Harten, Wim
|b 1
700 1 _ |a Retèl, Valesca P
|b 2
700 1 _ |a Pham, Phu Duy
|0 P:(DE-He78)e87b1ce9c94af84cffcf9279cece3738
|b 3
|u dkfz
700 1 _ |a Vancoppenolle, Julie M
|b 4
700 1 _ |a Ubels, Jasper
|0 P:(DE-He78)7586e13ade56c5b4d4cba2fc411b0cf0
|b 5
|u dkfz
700 1 _ |a López, Olaya Seoane
|b 6
700 1 _ |a Quirland, Camila
|b 7
700 1 _ |a Maza, Felipe
|b 8
700 1 _ |a Aas, Eline
|b 9
700 1 _ |a Crusius, Bernd
|b 10
700 1 _ |a Escobedo, Agustín
|b 11
700 1 _ |a Franzen, Nora
|b 12
700 1 _ |a Fuentes-Cid, Jeanette
|b 13
700 1 _ |a Hernandez, Diego
|b 14
700 1 _ |a Hernandez-Villafuerte, Karla
|b 15
700 1 _ |a Kirac, Iva
|b 16
700 1 _ |a Paty, Artus
|b 17
700 1 _ |a Philip, Thierry
|b 18
700 1 _ |a Smeland, Sigbjørn
|b 19
700 1 _ |a Sullivan, Richard
|b 20
700 1 _ |a Vanni, Elena
|b 21
700 1 _ |a Varga, Sinisa
|b 22
700 1 _ |a Vermeulin, Thomas
|b 23
700 1 _ |a Eckford, Rachel
|0 P:(DE-He78)9600624b0539f0fa9344e8936954b93d
|b 24
|e Last author
|u dkfz
773 _ _ |a 10.1016/S1470-2045(23)00636-8
|g Vol. 25, no. 4, p. e152 - e163
|0 PERI:(DE-600)2035574-9
|n 4
|p e152 - e163
|t The lancet / Oncology
|v 25
|y 2024
|x 1470-2045
909 C O |o oai:inrepo02.dkfz.de:289191
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)1f315d09721b91091df1ba78eb65cbaf
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)e87b1ce9c94af84cffcf9279cece3738
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)7586e13ade56c5b4d4cba2fc411b0cf0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 24
|6 P:(DE-He78)9600624b0539f0fa9344e8936954b93d
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-25
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b LANCET ONCOL : 2022
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-25
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-25
915 _ _ |a IF >= 50
|0 StatID:(DE-HGF)9950
|2 StatID
|b LANCET ONCOL : 2022
|d 2023-08-25
920 2 _ |0 I:(DE-He78)C100-20160331
|k C100
|l Gesundheitsökonomie
|x 0
920 1 _ |0 I:(DE-He78)C100-20160331
|k C100
|l Gesundheitsökonomie
|x 0
920 0 _ |0 I:(DE-He78)C100-20160331
|k C100
|l Gesundheitsökonomie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C100-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21